Surgical elevation of the forehead and brow for aesthetic improvement of the upper third of the aging face has been performed for nearly 100 years. 1 Open techniques traditionally relied on skin resection and brow repositioning to achieve desired results. These coronal approaches involve well-known negative sequelae, including paresthesias, numbness, scar widening, and alopecia, in addition to drawbacks with suboptimal tissue fixation and difficulty controlling brow shape. 2, 3 With the advent of minimally invasive techniques for facial aesthetic surgery in the early 1990s, surgeons began performing brow lifts without skin excision through much smaller incisions. 4, 5 The development of endoscopic browplasty highlighted the importance of tissue fixation, as opposed to excision (which was merely a method of fixation), as a key factor in the success of the operation. 6 Indeed, difficulty obtaining predictable tissue fixation was rapidly identified as a shortcoming of the endoscopic brow lift procedure. 3 Various tools and techniques were developed in attempts to provide secure fixation, including Mitek anchors (Mitek Worldwide, Norwood, Mass.), bone tunnels, microscrews, percutaneous fixation posts, Kirschner wires, fibrin glue, and miniplates, and in some cases, no fixation was used. [7] [8] [9] [10] [11] [12] [13] From private practice, the Department of Plastic and Reconstructive Surgery, Kaiser Permanente, and Department of Clinical Affairs, Coapt Systems, Inc. Received for publication June 8, 2004 Many of these techniques are thoroughly discussed by Rohrich and Beran. 6 To date, most fixation techniques have relied on a single point of fixation (i.e., one suture loop passed through tissue and secured, or a single percutaneous post serving as a tissue dam). A new absorbable device (Endotine Forehead; Coapt Systems, Inc., Palo Alto, Calif.), designed to distribute tension over multiple points of fixation, has recently been introduced. The device is composed of a bioabsorbable copolymer and consists of a platform, a post, and a series of five tines projecting from the platform. During use, the post is inserted into a small hole in the outer table of the cranium and the device is seated firmly against bone (subperiosteal). The untethered scalp/ forehead tissues are then lifted and suspended through tine penetration of the periosteum.
Early work has shown that the Endotine Forehead device provides rapid, predictable, and secure fixation without complications. 14 This report provides as detailed description of brow fixation, with preoperative and postoperative brow height measures, in a series of 21 patients.
PATIENTS AND METHODS
Between April of 2002 and September of 2003, 21 patients underwent an endoscopic brow lift (all procedures were performed at a single site by Dr. Berkowitz) with Endotine Forehead fixation. The first 15 patients (group 1, 14 women and one man) received the original Endotine device, which was made of a polylactide homopolymer and consisted of a 1-mm-thick platform and tines that projected 3.5 mm from the platform (Fig. 1) . One device was implanted on each side, anterior to the coronal suture and medial to the temporal fusion line, beneath hair-bearing scalp (Fig. 2) . The original device required drilling a cranial hole to 4.25 mm.
Group 1 patients underwent a series of concomitant procedures, detailed in Table I ). The remaining six patients (group 2, five women and one man) received the next-generation device (embodied in a much smaller total mass), composed of L-lactide/glycolide (82: 18), a more rapidly absorbing polymer. Five of them received the 3.0 version (tines projecting 3 mm from the platform) and one received the 3.5 version (tines projecting 3.5 mm from the platform). The cranial drill hole in this group was limited to 3.95 mm. These six patients also underwent additional procedures, also detailed in Table I . Placement of the device was identical in both groups.
Full-size, 1:1, standardized black-and-white photographs (Frankfort horizontal plane) were taken of each patient 4 to 6 weeks before surgery. An additional set of photographs was taken postoperatively. The postoperative photographs included at least one image with a scale (cm and mm) to validate measurement accuracy. From a horizontal line drawn through the medial canthi, the following three measurements were taken from each side of the before and after images ( 1. On a perpendicular line passing through the midpupil to the superior margin of the eyebrow (hereafter referred to as the "superior brow") 2. On a perpendicular line passing through the midpupil to the hairline 3. On a perpendicular line passing through the lateral canthus to the superior brow
The measurements were recorded and compared.
RESULTS
Twenty-one patients were evaluated, with follow-up ranging from 54 to 174 days (average follow-up, 102 days, or 14.6 weeks). There were no reports of pain, device extrusion, device removal, numbness, paresthesias, or alopecia. No additional surgery was required to revise or maintain the desired result. Table II shows raw measurement data for the midpupil and lateral canthus to superior brow distances. Group 1 patients (n ϭ 15) received elevations averaging 4.3 to 4.8 mm (range, 1 to 13 mm) (Table III) . A representative patient result is shown in Figure 4 . Group 2 patients (n ϭ 6) received elevations averaging 3.5 to 5.0 mm (range, 1 to 8 mm) (Table IV) . A representative patient result is shown in Figure 5 . The combined group (21 patients) received elevations averaging 4.2 to 4.8 mm (range, 1 to 13 mm) ( Table V) .
DISCUSSION
The long-term efficacy of endoscopic brow lift has been a subject of debate. Others have used brow height change as a marker for success, with results ranging from approximately 2 mm to more than 6 mm and, in some cases, 10 to 12 mm. 12, 15, 16 Maximum brow height elevation alone is often not the operative goal, as predicting brow height change is limited by the surgeon's inability to predict the effect of frontalis muscle relaxation. Other factors, including brow shape and overall aesthetic balance, must be considered when assessing outcomes. However, dissatisfaction with the endoscopic brow lift procedure is often related to suboptimal vertical height change. As such, assessing measurable differences in preoperative and postoperative brow height does provide an objective standard among multiple factors used to evaluate brow lift outcomes.
Many believe that a key factor in achieving a prolonged and stable lift is the extent to which effective fixation is maintained. The shortterm methods (taping, percutaneous screws, and so on), in addition to poorly distributing the tensile forces, do not provide support throughout the critical early healing period. Studies have shown that it can take up to 6 weeks for elevated periosteum to re-adhere to underlying bone, and some advocate maintaining fixation for at least 6 to 8 weeks postoperatively. 7, 17, 18 Other factors influence outcome, including weakening of brow depressors and the extent of periosteal, orbicularis, and restraining ligament release along the orbital rim.
The Endotine device provides effective fixation during healing. The multipoint fixation concept appeared to successfully provide several points of contact to distribute the postoperative regressive forces over a broader surface area than single-point fixation. Average elevations of 4.2 to 4.8 mm, as measured across three points bilaterally, were obtained. The three points were chosen because they reveal measurable vertical change over three regions. The devices were well tolerated by the patients, and none required removal. Use of the device was intuitive and rapid.
Patient follow-up did not exceed 6 months in this study. The device material used in group 1 is known to absorb slowly (well over 12 months), while group 2 received devices composed of a copolymer that is fully resorbed, in vitro, within 12 months. In both cases, device integrity is maintained well beyond the critical healing period, thus providing mechanical fixation until sufficient biological fixation has taken place.
The original device was offered with 3.5-mm tines to ensure the tines would penetrate the periosteum. The current Endotine Forehead device is available with 3.0-mm tines, in addi- 30  30  29  29  30  31  174  11  26  21  28  24  24  25  27  26  89  12  24  21  28  25  24  23  29  26  139  13  17  16  25  23  17  19  25  26  103  14  23  24  28  27  25  25  29  29  104  15  22  19  27  24  19  19  26  25  81  16  22  22  27  30  25  25  30  33  88  17  26  24  30  27  26  24  28  27  88  18  20  20  25  25  19  21  24  25  84  19  21  19  28  26  21  21  30  29  82  20  25  21  27  23  26  22  28  24  77  21  23  21  24  26  22  24  25  27  168 POD, postoperative day. There was no evidence of numbness, paresthesias, or alopecia associated with use of this device. The absence of alopecia may be due to relatively less tension in a given tissue unit due to multiple points of suspension. This phenomenon provides for diminished local tissue compression and may provide an improved healing environment with subsequent positive effects on scar formation.
Recent reports have indicated that the number of endoscopic brow lift cases is declining and that practitioners find the open (coronal) approach more effective for obtaining brow-lifting goals. 19, 20 The Endotine Forehead device may allow a return to the more minimally invasive endoscopic approach by providing a simple, effective, and predictable solution to the problem of brow fixation in endoscopic browplasty. 
